Free Trial

Alcon (ALC) Stock Forecast & Price Target

$91.74
+1.20 (+1.33%)
(As of 07/12/2024 ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$94.92
3.47% Upside
High Forecast$105.00
Average Forecast$94.92
Low Forecast$65.00
TypeCurrent Forecast
7/14/23 to 7/13/24
1 Month Ago
6/14/23 to 6/13/24
3 Months Ago
4/15/23 to 4/14/24
1 Year Ago
7/14/22 to 7/14/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
4 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$94.92$94.71$91.22$84.00
Forecasted Upside3.47% Upside12.42% Upside12.61% Upside19.28% Upside
Get Alcon Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alcon Stock vs. The Competition

TypeAlconMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside3.47% Upside994.21% Upside9.17% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/12/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$101.00 ➝ $101.00+11.55%
5/15/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$89.00 ➝ $94.00+4.68%
5/15/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$95.00 ➝ $104.00+16.50%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00+12.02%
5/15/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+17.62%
5/15/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$103.00+15.38%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.95%
3/14/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Perform
3/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$90.00 ➝ $100.00+16.31%
2/29/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$87.00 ➝ $92.00+7.39%
2/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.60+13.10%
12/18/2023Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$85.00 ➝ $65.00-14.30%
11/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$94.00 ➝ $88.00+23.40%
8/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$79.80 ➝ $89.30+11.29%
7/17/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$88.00 ➝ $91.00+7.27%
3/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
11/21/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetCHF 84 ➝ CHF 80
11/17/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$67.00 ➝ $69.00+4.03%
8/16/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetCHF 88 ➝ CHF 83.80

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:11 PM ET.

ALC Forecast - Frequently Asked Questions

What is Alcon's forecast for 2024?

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $94.92, with a high forecast of $105.00 and a low forecast of $65.00.

Should I buy or sell Alcon stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 2 sell ratings, 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALC shares.

Does Alcon's stock price have much upside?

According to analysts, Alcon's stock has a predicted upside of 11.72% based on their 12-month stock forecasts.

Has Alcon been upgraded by Wall Street analysts recently?

Over the previous 90 days, Alcon's stock had 1 upgrade by analysts.

What analysts cover Alcon?

Alcon has been rated by research analysts at Mizuho, Needham & Company LLC, Oppenheimer, Robert W. Baird, Stifel Nicolaus, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Alcon more than its competitors?

Analysts like Alcon less than other "medical" companies. The consensus rating score for Alcon is 2.67 while the average consensus rating score for "medical" companies is 2.71. Learn more on how ALC compares to other companies.


This page (NYSE:ALC) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners